Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
E Ryan, V Byrnes, B Coughlan, AM Flanagan, S Barrett… - Gut, 2002 - gut.bmj.com
E Ryan, V Byrnes, B Coughlan, AM Flanagan, S Barrett, JC O'Keane, J Crowe
Gut, 2002•gut.bmj.comBackground: The majority of hereditary haemochromatosis (HH) patients are homozygous
for the C282Y mutation in the HFE gene. We have demonstrated a homozygote frequency of
1 in 83 for the C282Y mutation in a retrospective analysis of Irish neonates. However, a fully
developed phenotype is not observed at the same frequency clinically, suggesting that a
large proportion of Irish HH patients may remain undiagnosed. Aims: To determine whether
underdiagnosis of HH results from the non-specific nature of early symptoms or incomplete …
for the C282Y mutation in the HFE gene. We have demonstrated a homozygote frequency of
1 in 83 for the C282Y mutation in a retrospective analysis of Irish neonates. However, a fully
developed phenotype is not observed at the same frequency clinically, suggesting that a
large proportion of Irish HH patients may remain undiagnosed. Aims: To determine whether
underdiagnosis of HH results from the non-specific nature of early symptoms or incomplete …
Background: The majority of hereditary haemochromatosis (HH) patients are homozygous for the C282Y mutation in the HFE gene. We have demonstrated a homozygote frequency of 1 in 83 for the C282Y mutation in a retrospective analysis of Irish neonates. However, a fully developed phenotype is not observed at the same frequency clinically, suggesting that a large proportion of Irish HH patients may remain undiagnosed.
Aims: To determine whether underdiagnosis of HH results from the non-specific nature of early symptoms or incomplete penetrance of the C282Y mutation.
Methods: Seventy nine C282Y homozygous individuals identified from family screening for HH and 30 HH probands were investigated. Non-specific symptoms (fatigue, arthropathy, and impotence) and their association with iron indices (transferrin saturation and serum ferritin) and hepatic iron deposition were analysed.
Results: We found that 78% of men (mean age 42 years) and 36% of women (mean age 39 years) who were identified as C282Y homozygotes following family screening had iron overload, as defined by a transferrin saturation ≥52% combined with a serum ferritin ≥300 μg/l for men and ≥200 μg/l for women. The frequency of reports of non-specific symptoms in those individuals with iron overload was not significantly different from those who did not have iron overload.
Conclusions: Our findings indicate that underdiagnosis of HH may be due to the non-specific nature of early symptoms and less frequently to the incomplete penetrance of the C282Y mutation.
gut.bmj.com